Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protease‐activated prodrugs: strategies, challenges, and future directions
Marcin Poręba
FEBS Journal (2020) Vol. 287, Iss. 10, pp. 1936-1969
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Antibody–drug conjugates come of age in oncology
Charles Dumontet, Janice M. Reichert, Peter D. Senter, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 641-661
Closed Access | Times Cited: 366
Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs)
Bethany Cooper, Jessica Iegre, Daniel H. O’Donovan, et al.
Chemical Society Reviews (2020) Vol. 50, Iss. 3, pp. 1480-1494
Open Access | Times Cited: 286
Human Gut Microbiota and Drug Metabolism
Archana Pant, Tushar Kanti Maiti, Dinesh Mahajan, et al.
Microbial Ecology (2022) Vol. 86, Iss. 1, pp. 97-111
Open Access | Times Cited: 96
Potential of antibody–drug conjugates (ADCs) for cancer therapy
Hany E. Marei, Carlo Cenciarelli, Anwarul Hasan
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 81
Activity-Based Fluorescence Diagnostics for Cancer
Kyohhei Fujita, Yasuteru Urano
Chemical Reviews (2024) Vol. 124, Iss. 7, pp. 4021-4078
Closed Access | Times Cited: 33
Transferrin receptor targeting chimeras for membrane protein degradation
Dingpeng Zhang, Jhoely Duque-Jimenez, Francesco Facchinetti, et al.
Nature (2024)
Closed Access | Times Cited: 30
Prodrug-based bispecific antibodies for cancer therapy: advances and future directions
Zhengdong Ai, Bing Wang, Yunlong Song, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 2
Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency
Dian Su, Donglu Zhang
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 91
The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy
Matej Vizovišek, Dragana Ristanović, Stefano Menghini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2514-2514
Open Access | Times Cited: 68
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control
Roberta Lucchi, Jordi Bentanachs, Benjamí Oller‐Salvia
ACS Central Science (2021) Vol. 7, Iss. 5, pp. 724-738
Open Access | Times Cited: 64
Peptide-based delivery of therapeutics in cancer treatment
Timothy Samec, Jessica Boulos, Serena Gilmore, et al.
Materials Today Bio (2022) Vol. 14, pp. 100248-100248
Open Access | Times Cited: 50
Conditional Antimicrobial Peptide Therapeutics
Chayanon Ngambenjawong, Leslie W. Chan, Heather E. Fleming, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 15779-15791
Open Access | Times Cited: 44
Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents
Jesse M. McFarland, Maša Alečković, George Coricor, et al.
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1400-1408
Open Access | Times Cited: 26
Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates
Seetharamsing Balamkundu, Chuan‐Fa Liu
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3080-3080
Open Access | Times Cited: 26
Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody–Drug Conjugates
Tomohiro Watanabe, Naoko Arashida, Tomohiro Fujii, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 20, pp. 18124-18138
Open Access | Times Cited: 9
Antibacterials with Novel Chemical Scaffolds in Clinical Development
Dominik Heimann, Daniel Kohnhäuser, Alexandra Jana Kohnhäuser, et al.
Drugs (2025)
Open Access | Times Cited: 1
Synthesis and Characterization of Polymer‐Drug Conjugates by Strain‐Promoted Azide‐Alkyne Cycloaddition‐Mediated Polymerization
Omotola D. Gbadegesin, Simeon K. Adesina
Journal of Applied Polymer Science (2025)
Closed Access | Times Cited: 1
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
Martina Geiger, Kay‐Gunnar Stubenrauch, Johannes Sam, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 63
SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non‐Injected Lesions
Sangeetha Srinivasan, Nathan A. Yee, Kui Wu, et al.
Advanced Therapeutics (2021) Vol. 4, Iss. 3
Open Access | Times Cited: 52
Linkers: A synergistic way for the synthesis of chimeric proteins
Dharti Patel, Dhanya V. Menon, Darshan Patel, et al.
Protein Expression and Purification (2021) Vol. 191, pp. 106012-106012
Closed Access | Times Cited: 42
Robust antibacterial activity of functionalized carbon nanotube- levofloxacine conjugate based on in vitro and in vivo studies
Marzieh Hassani, Azar Tahghighi, Mahdi Rohani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Clickable polysaccharides for biomedical applications: A comprehensive review
Mohsen Khodadadi Yazdi, S. Mohammad Sajadi, Farzad Seidi, et al.
Progress in Polymer Science (2022) Vol. 133, pp. 101590-101590
Open Access | Times Cited: 37
The Mammalian Cysteine Protease Legumain in Health and Disease
Rigmor Solberg, Ngoc Nguyen Lunde, Karl Martin Forbord, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15983-15983
Open Access | Times Cited: 32
Non-Canonical Amino Acids in Analyses of Protease Structure and Function
Peter Goettig, Nikolaj G. Koch, Nediljko Budiša
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14035-14035
Open Access | Times Cited: 17
In silico evolution of autoinhibitory domains for a PD-L1 antagonist using deep learning models
Odessa J. Goudy, Amrita Nallathambi, Tomoaki Kinjo, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top